BONE BIOLOGICS CORPORATION
2 Burlington Woods Drive, Suite 100
Burlington, MA 01803
July 7,2022
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
| Re: | Bone Biologics Corporation. | |
| Registration Statement on Form S-3 | ||
| Filed June 28,2022 | ||
| File No. 333-265872 |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Bone Biologics Corporation., a Delaware corporation, respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 4:00 p.m., Eastern Time, on Monday, July 11,2022, or as soon thereafter as is practicable. Please call our counsel, David L. Ficksman of TroyGould PC at 310-789-1290 to provide notice of effectiveness.
| Very truly yours, | ||
| BONE BIOLOGICS CORPORATION. | ||
| By: | /s/ Jeffrey Frelick | |
| Jeffrey Frelick | ||
| Chief Executive Officer | ||